EAISE Study

Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke

Temporoparietal brain hemorrhage shown on an MRI scan

AGE: 30 to 90 years
SEX AT BIRTH: All
TYPE: Investigational Drug Study
CONDITION: Acute Ischemic Stroke
HEALTHY PARTICIPANTS: No
LOCATION: UH Cleveland Medical Center

Learn More About This Research Study

For more information, please contact study coordinator, Mary Andrews at 216-844-1800 and leave a message or complete the online form below.

Study Purpose

The purpose of this study is to evaluate if the investigational drug, elezanumab, is safe and able to improve cognitive and/or motor functioning in an individual following the occurrence of acute ischemic stroke.

Who Can Participate

Participants who were diagnosed with an acute ischemic stroke maybe eligible for this study.

Request More Information

Please complete the form below to be contacted by a study representative and learn more about this study.

Requestor's Information

XXX-XXX-XXXX

Study ID

  • STUDY20200610